description Johnson & Johnson (JNJ) Overview
Johnson & Johnson is a diversified healthcare company operating in pharmaceuticals, medical devices, and consumer health. Its diverse business segments provide resilience against economic fluctuations and sector-specific challenges. Like P&G, J&J is a Dividend Aristocrat with a long history of dividend increases. While the company recently spun off its consumer health division (Kenvue), the remaining businesses are highly profitable and generate significant cash flow.
The current dividend yield is approximately 2.8%, and its strong research and development capabilities drive innovation and growth. It's a good choice for investors seeking a stable income stream from a leading healthcare company.
info Johnson & Johnson (JNJ) Specifications
| Sector | Healthcare |
| Founded | 1886 |
| Employees | Approximately 130,000 |
| Market Cap | Approximately $400 Billion (as of late 2023) |
| Headquarters | New Brunswick, New Jersey, USA |
| R&D Spending | Approximately $11.5 Billion annually |
| Stock Ticker | JNJ |
| Geographic Reach | Global, with significant operations in North America, Europe, and Asia-Pacific |
| Business Segments | Pharmaceutical, Medical Devices, (formerly) Consumer Health |
balance Johnson & Johnson (JNJ) Pros & Cons
- Diversified Business Segments: Operates across pharmaceuticals, medical devices, and consumer health, mitigating risk from sector downturns.
- Dividend Aristocrat: Demonstrates a commitment to rewarding shareholders with consistently increasing dividend payments for decades.
- Strong Financial Stability: Johnson & Johnson consistently maintains a robust balance sheet and generates significant cash flow.
- Global Presence: Extensive international operations provide access to diverse markets and reduce reliance on any single region.
- Innovation Pipeline: Continues to invest heavily in research and development, fostering a pipeline of potential new products and therapies.
- Brand Recognition & Trust: Possesses globally recognized brands with a reputation for quality and reliability, fostering customer loyalty.
- Litigation Risk: Faces ongoing legal challenges related to product liability, which can impact financial performance and reputation.
- Exposure to Healthcare Regulations: Subject to stringent and evolving healthcare regulations, potentially increasing compliance costs.
- Consumer Health Spin-off: The recent spin-off of Kenvue (consumer health division) introduces uncertainty and potential integration challenges.
- Generic Competition: Pharmaceutical products face increasing competition from generic alternatives, impacting revenue and profitability.
- Macroeconomic Sensitivity: While diversified, J&J's performance can still be affected by broader economic conditions and healthcare spending trends.
help Johnson & Johnson (JNJ) FAQ
What is Johnson & Johnson's dividend yield?
Johnson & Johnson's dividend yield fluctuates with the stock price but typically ranges between 2.5% and 3.5%. It's a consistent dividend payer, but yields can vary based on market conditions and stock valuation.
How does Johnson & Johnson's pharmaceutical segment perform?
The pharmaceutical segment is J&J's largest and most profitable, driven by blockbuster drugs and a strong pipeline. Performance is influenced by patent expirations, regulatory approvals, and competition from biosimilars.
What was the impact of the Kenvue spin-off?
The spin-off of Kenvue, Johnson & Johnson's consumer health business, aims to focus J&J on pharmaceuticals and medical devices. It simplifies the company's structure but introduces uncertainty regarding Kenvue's future performance.
What are some of Johnson & Johnson's key medical device products?
J&J's medical device portfolio includes surgical equipment, orthopedics (hip and knee replacements), cardiovascular devices, and vision care products. They are leaders in many of these specialized areas.
What is Johnson & Johnson (JNJ)?
How good is Johnson & Johnson (JNJ)?
What are the best alternatives to Johnson & Johnson (JNJ)?
What is Johnson & Johnson (JNJ) best for?
Johnson & Johnson is ideal for long-term, risk-averse investors seeking a stable dividend income and exposure to the healthcare sector.
How does Johnson & Johnson (JNJ) compare to AbbVie (ABBV)?
Is Johnson & Johnson (JNJ) worth it in 2026?
What are the key specifications of Johnson & Johnson (JNJ)?
- Sector: Healthcare
- Founded: 1886
- Employees: Approximately 130,000
- Market Cap: Approximately $400 Billion (as of late 2023)
- Headquarters: New Brunswick, New Jersey, USA
- R&D Spending: Approximately $11.5 Billion annually
explore Explore More
Similar to Johnson & Johnson (JNJ)
See all arrow_forward
Reviews & Comments
Write a Review
Be the first to review
Share your thoughts with the community and help others make better decisions.
